Infectious Disease & Vaccines

Tardigrades survive heat, freezing, and even space radiation. Now, researchers translate lessons learned from these creatures into more stable drug formulations and new health insights.

By engineering a probiotic with tiny antibodies from alpacas, scientists created a potential new oral tool to treat deadly diarrheal infections.

Legislation now allows some drugs to skip animal testing, but it’s unclear when, if ever, this step will be gone for good.

Spatial biology studies allow scientists to gain deeper insights into infectious disease transmission and pathobiology across various tissues.

Immune evasion by infectious pathogens complicates the development of new vaccines. 

Most vaccines and biologics must stay cold until ready for use, but new thin film technology stabilizes these therapeutics for months at room temperature.

As scientific conferences return to in person programming, we still need COVID-19 precautions.

Researchers are rooting through the concoction of compounds in exhaled breath vapor for metabolic manifestations of COVID-19 and cancer.

Therapeutics that mimic or manipulate components of mucus may protect against deadly infections.

Denise Kirschner developed an equation-based lung model of a fatal but forgotten infectious disease, revealing an unexpected role for math in drug discovery.

Symptomatic rabies has no cure, but recent advances in rabies structural biology and antibody cocktails point to better treatments on the horizon.

As self-assembling structures, DNA and RNA origami vaccines hold vaccine components in precise numbers and arrangements to help the immune system attack tumors.